Clinical Trials Directory

Trials / Completed

CompletedNCT00996489

This is a Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence

Post-approval of Coaptite® in the Treatment of Female Urinary Incontinence

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
459 (actual)
Sponsor
Merz North America, Inc. · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a post approval study of Coaptite® in the treatment of female urinary incontinence.

Conditions

Interventions

TypeNameDescription
DEVICECoaptite®Calcium hydroxylapatite particles suspended in an aqueous based gel carrier

Timeline

Start date
2008-01-08
Primary completion
2015-10-26
Completion
2015-11-02
First posted
2009-10-16
Last updated
2019-07-23
Results posted
2019-07-23

Locations

20 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00996489. Inclusion in this directory is not an endorsement.

This is a Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence (NCT00996489) · Clinical Trials Directory